+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vivus - logo

VIVUS is a biopharmaceutical company that develops and commercializes therapies to address unmet medical needs in the United States and the European Union. The company’s lead product Qsymia is a combination appetite suppressant/stimulant and seizure medication indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in overweight and obese adults. VIVUS was founded in 1991 and is headquartered in Campbell, California.

Global Anti-Obesity Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Mechanism of Action, By Route Of Administration (Oral Route and Subcutaneous Route), By Distribution Channel, By Regional Outlook and Forecast, 2023-2029 - Product Thumbnail Image

Global Anti-Obesity Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Mechanism of Action, By Route Of Administration (Oral Route and Subcutaneous Route), By Distribution Channel, By Regional Outlook and Forecast, 2023-2029

  • Report
  • April 2023
  • 220 Pages
  • Global
From
Obesity Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type - Product Thumbnail Image

Obesity Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

  • Report
  • February 2024
  • 87 Pages
  • Global
From
Anti-obesity Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type - Product Thumbnail Image

Anti-obesity Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

  • Report
  • January 2024
  • 89 Pages
  • Global
From
Europe Anti-Obesity Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Mechanism of Action, By Route Of Administration (Oral Route and Subcutaneous Route), By Distribution Channel, By Country and Growth Forecast, 2023-2029 - Product Thumbnail Image

Europe Anti-Obesity Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Mechanism of Action, By Route Of Administration (Oral Route and Subcutaneous Route), By Distribution Channel, By Country and Growth Forecast, 2023-2029

  • Report
  • April 2023
  • 83 Pages
  • Europe
From
Asia Pacific Anti-Obesity Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Mechanism of Action, By Route Of Administration (Oral Route and Subcutaneous Route), By Distribution Channel, By Country and Growth Forecast, 2023-2029 - Product Thumbnail Image

Asia Pacific Anti-Obesity Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Mechanism of Action, By Route Of Administration (Oral Route and Subcutaneous Route), By Distribution Channel, By Country and Growth Forecast, 2023-2029

  • Report
  • April 2023
  • 84 Pages
  • Asia Pacific
From
LAMEA Anti-Obesity Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Mechanism of Action, By Route Of Administration (Oral Route and Subcutaneous Route), By Distribution Channel, By Country and Growth Forecast, 2023-2029 - Product Thumbnail Image

LAMEA Anti-Obesity Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Mechanism of Action, By Route Of Administration (Oral Route and Subcutaneous Route), By Distribution Channel, By Country and Growth Forecast, 2023-2029

  • Report
  • April 2023
  • 84 Pages
  • Middle East, Africa
From
North America Anti-Obesity Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Mechanism of Action, By Route Of Administration (Oral Route and Subcutaneous Route), By Distribution Channel, By Country and Growth Forecast, 2023-2029 - Product Thumbnail Image

North America Anti-Obesity Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Mechanism of Action, By Route Of Administration (Oral Route and Subcutaneous Route), By Distribution Channel, By Country and Growth Forecast, 2023-2029

  • Report
  • April 2023
  • 72 Pages
  • North America
From
Oral Biologics & Biosimilars Global Market Report 2024 - Product Thumbnail Image

Oral Biologics & Biosimilars Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Global Erectile Dysfunction (ED) Drugs Market 2024-2028 - Product Thumbnail Image

Global Erectile Dysfunction (ED) Drugs Market 2024-2028

  • Report
  • November 2023
  • 163 Pages
  • Global
From
Global Phosphodiesterase (PDE) Inhibitors Market 2024-2028 - Product Thumbnail Image

Global Phosphodiesterase (PDE) Inhibitors Market 2024-2028

  • Report
  • December 2023
  • 165 Pages
  • Global
From
Drugs for Erectile Dysfunction Global Market Report 2024 - Product Thumbnail Image

Drugs for Erectile Dysfunction Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Erectile Dysfunction Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023- 2028) - Product Thumbnail Image

Erectile Dysfunction Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023- 2028)

  • Report
  • April 2023
  • 115 Pages
  • Global
From
Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) - Drugs in Development, 2021 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
Anti-Obesity Therapeutics Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Anti-Obesity Therapeutics Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • March 2022
  • 98 Pages
  • Global
From
Obesity - Pipeline Review, H2 2020 - Product Thumbnail Image

Obesity - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 640 Pages
  • Global
From
Anti Obesity Prescription Drugs Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Anti Obesity Prescription Drugs Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • May 2021
  • 77 Pages
  • Global
From
Obesity: Competitive Landscape to 2026 - Product Thumbnail Image

Obesity: Competitive Landscape to 2026

  • Report
  • October 2018
  • 50 Pages
  • Global
From
Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 589 Pages
  • Global
From
Global Erectile Dysfunction Treatment Market - Focused Insights 2024-2029 - Product Thumbnail Image

Global Erectile Dysfunction Treatment Market - Focused Insights 2024-2029

  • Report
  • February 2024
  • 122 Pages
  • Global
From
Lipid Nanoparticles in Drug Delivery: Intellectual Property Landscape - Product Thumbnail Image

Lipid Nanoparticles in Drug Delivery: Intellectual Property Landscape

  • Report
  • March 2023
  • 182 Pages
  • Global
From
Loading Indicator